Australian-made RATs await TGA approval amid rapid antigen test shortage Read more
Blog
AnteoTech is pleased to advise that it has renewed its contract with leading healthcare diagnostic partner Ellume Ltd. (“Ellume”) for the supply of AnteoBind to be used in Ellume’s range of tests. Ellume is an Australia-based diagnostics company that develops, manufactures and commercialises high-performance connected products for health professionals and consumers. Most recently, Ellume becameRead more
AnteoTech broadens European market exposure, securing a Spanish and Portuguese Distribution Agreement for EuGeni AnteoTech is pleased to welcome another newly appointed distributor to the EuGeni family. Most recently, AnteoTech has appointed Vitro Master Diagnostica (Vitro) for Spain and Portugal, the sixth exclusive distributor in Europe. Following the appointment, Vitro Master Vitro S.A. and itsRead more
AnteoTech welcomes EXXE S.r.l (EXXE) to the EuGeni family. Based in Milan, Italy, EXXE is AnteoTech’s fifth European distributor for the EuGeni Reader platform and SARS-CoV-2 Antigen Rapid Diagnostic Test (RDT). We are excited at the ongoing momentum shown by the rapid expansion of our distributor base in Europe as we continue to lay theRead more
Recent Comments